Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, prevents microparticle-induced vascular hyporeactivity through the regulation of proinflammatory proteins

  1. Tesse, A.
  2. Al-Massarani, G.
  3. Wangensteen, R.
  4. Reitenbach, S.
  5. Martínez, M.C.
  6. Andriantsitohaina, R.
Journal:
Journal of Pharmacology and Experimental Therapeutics

ISSN: 1521-0103,  0022-3565

Year of publication: 2008

Volume: 324

Issue: 2

Pages: 539-547

Type: Article

DOI: 10.1124/JPET.107.130278 GOOGLE SCHOLAR
Data source: Scopus